ECEESPE2025 Poster Presentations Growth Axis and Syndromes (91 abstracts)
Early growth hormone treatment enhances growth and nutritional status in silver-russell syndrome
Eloise Giabicani 1 , Raphaelle Billette de Villemeur 1 , Melodie Acher 1 , Manon Cochet 1 , Béatrice Dubern 1 & Irene Netchine 1
1Sorbonne Université, Assistance Publique Hôpitaux de Paris, Paris, France
JOINT1748
Context: Silver-Russell syndrome (SRS) is an imprinting disorder characterized by severe intrauterine and postnatal growth retardation, feeding difficulties, and risk of hypoglycaemia. Recombinant growth hormone (rGH) therapy has shown its positive effect on adult height in SRS.
Objective: We aimed to assess the short-term effects of rGH therapy on the growth and nutritional status of these patients. Design, patients and settingsRetrospective monocentric data of growth and nutritional characteristics of 77 prepubertal patients with molecularly proven SRS during the first two years of rGH therapy were analysed.
Results: The mean age at the initiation of rGH therapy was 3. 7 (1. 4-10. 3) years. The mean height gain was 0. 8 standard deviation score (SDS) after one year of treatment and 1. 3 SDS after two years. The ideal weight for length/height (WfH), reflecting the nutritional status, increased from a mean of 81% at rGH initiation, to 84% after one year of treatment (p < 0. 001) and 86% after two years (p < 0. 001). The proportion of SRS patients below a WfH of 75% decreased from 22. 1% at rGH therapy initiation to 7. 8% after two years of treatment. Starting rGH therapy before the age of four years was associated with a greater increase in height after two years, 1. 5 vs 1. 1 SDS, P = 0. 012.
Conclusions: In prepubertal SRS patients, the first two years of standard-dose rGH therapy significantly enhance both height and nutritional status. Early initiation of treatment, before the age of four years, further optimizes height gain.
Volume 110
Article tools
My recent searches
My recently viewed abstracts
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more